Antimicrobial resistance of different Acinetobacter baumannii biotypes isolated in the northern region of Chile;Resistencia a antimicrobianos en diferentes biotipos de Acinetobacter baumannii aislados en el norte de Chile

Revista Medica de Chile

Volumn 127, Issue 8, 1999, Pages 926-934

  Silva A, Juan ^a   Avello C, Carmen ^a   Matamoro R, Fernando ^a   Villagra M, Lorena ^a   Rojas S, Verónica ^a   Sandoval L, Lilian ^a  

^a UNIVERSIDAD DE ANTOFAGASTA   (Chile)

Author keywords

Acinetobacter infectious, Drug resistance, microbial; Imipenem

Indexed keywords

ACINETOBACTER; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIUM IDENTIFICATION; CHILE; CLASSIFICATION; CROSS INFECTION; DRUG EFFECT; HUMAN; ISOLATION AND PURIFICATION; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY;

ACINETOBACTER; BACTERIAL TYPING TECHNIQUES; CHILE; CROSS INFECTION; DRUG RESISTANCE, MICROBIAL; HUMANS; MICROBIAL SENSITIVITY TESTS;

EID: 0033170995     PISSN: 00349887     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. BERGOGNE-BÉRÉZIN E, JOLY-GUILLOU ML. An understimated nosocomial pathogen, Acinetobacter calcoaceticus. J Antimicrob Chemother 1985; 16: 535-8.
2. HARTSTEIN AI, RASHAD AL, LIEBLER JM, ACTIS LA, FREEMAN J, ROURKE JW ET AL. Multiple intensive care unit outbreak of Acinetobacter calcoaceticus subspecies anitratus respiratory infections and colonization associated with contaminated, reusable ventilator circuits and resucitation bags. Am J Med 1988; 85: 624-31.
3. SEIFERT H, STRATE A, PULVERER G. Nosocomial bacteria due to Acinetobacter baumannii clinical features, epidemiology and predictions of mortality. Medicine 1995; 74: 340-9.
4. TRIANTAFILO V, PIWONKA V, NASRA J, RUIZ G, AORSI B, SILVA M. Bacteremias por Acinetobacter baumannii. Rev Chil Infectol 1990; 7: 235-7.
5. VIVANCO G, FIGUEROA A. Septicemia intrahospitalaria por Acinetobacter calcoaceticus var anitratus. Rev Chil Pediatr 1991; 62: 297-301.
6. FERNÁNDEZ A. Acinetobacter calcoaceticus ssp anitratus ¿un grave problema intrahospitalario? Boletín Hospital San Juan de Dios (Chile) 1991; 38: 282-5.
7. JUNI E. Genus II Acinetobacter. Brisou et Prevot 1954. En: Krieg NR, Holt JG, ed. Bergey's Manual of Systematic Bacteriology, vol 1 The Williams Co Baltimore 1984; 303-7.
8. CEFAI C, RICHARDS J, GOULD FK, MCPEAKE P. An outbreak of Acinetobacter respiratory tract infection, resulting from an incomplete desinfection of ventilatory equipment. J Hosp Infect 1990; 15: 117-82.
9. SCHLOESSER RI, LAUFKOTTER EA, LEHNERS T, MIETENS C. An outbreak of Acinetobacter calcoaceticus infection in neonatal unit. Infection 1990; 18: 230-3.
10. SEIFERT H, GAGINSKI R, SCHULZE A, PULVERER G. Antimicrobial susceptibility of Acinetobacter species. Antimicrob Ag Chemother 1993; 37: 750-3.
11. JOLY-GUILLOU M, BERGOGNE-BÉRÉZIN E, VIEU J. Epidemiologie et résistance aux antibiotiques des Acinetobacter en milieu hospitalier. Presse Med 1990; 19: 357-61.
12. BOUVET PJM, GRIMONT PAD. Taxonomy of the genus Acinetobacter with the recognition of Acinetobacter baumannii sp nov, Acinetobacter johnsonii sp nov, and Acinetobacter juni sp nov and enmended descriptions of Acinetobacter calcoaceticus and Acinetobacter Iwoffii. Int J Syst Bacteriol 1986; 36: 228-40.
13. BOUVET PJM, GRIMMONT PAD. Identification and biotyping of clinical isolates of Acinetobacter. Ann Rev Microbiol 1987; 138: 569-78.
14. GARCÍA S, MARTÍNEZ MA, PINTO ME. Biotipificación de cepas de Acinetobacter baumannii aisladas de infecciones intra-hospitalarias. Rev Chil Infectol 1991; 8: 83-6.
15. DOMÍNGUEZ M, GONZÁLEZ G, BELLO H, GARCÍA A, MELLA S, PINTO ME ET AL. Identification and biotyping of Acinetobacter spp isolated in Chilean hospitals. J Hosp Infect 1995; 30: 267-71.
16. SILVA J, HERRERA N, AVELLO C, MATAMORO F. Susceptibilidad a agentes antimicrobianos de cepas clínicas de Acinetobacter baumannii aisladas en el norte de Chile. Anal Microbiol Chile 1994; 2: 8-10.
17. SILVA AVALOS J, RICHMOND R, NAGAPAN O, KUNZ D. Degradation of metal cyano-complex tetracyanonickelate (II) by cyanide-utilizing bacteria. Appl Environ Microbiol 1991; 56: 3664-70.
18. SILVA J, HERRERA N, URDANIVIA R, BECERRA S, GODOY J, ANDERSON H ET AL. Actividad in vitro de cefotaxima (HR 756), comparada con cefalexina, gentamicina y amikacina sobre bacterias Gram negativas en infecciones urinarias. Rev Méd Chile 1983; 111: 699-703.
19. NATIONAL COMMITTEE FOR CLINICAL LABORATORY STANDARDS. Methods for dilution antimicrobial susceptibility test for bacteria that grow aerobically, 2nd de M7-A2 National Commiittee for Clinical Laboratory Standards, Villanova, PA. 1990.
20. MARTÍNEZ MA, PINTO ME, GIGLIO MS, POMMIER J, MUÑOZ L. Identificación y susceptibilidad de Acinetobacter sp aislados en muestras clínicas y ambiente hospitalario. Rev Méd Chile 1992; 120: 1267-72.
21. FRENCH GL, CASEWELL MW, RONCOROMI AJ, KNIGHT J, PHILLIPS I. A hospital outbreak of antibiotic resistant Acinetobacter anitratus: epidemiology and control. J Hosp Infect 1980; 1: 125-31.
22. TIMSIT JF, GARRAIT V, MISSEL B, GOLDSTEIN FW, RENAUD B, CARLET J. The digestive tract as major site for Acinetobacter baumannii colonization in intensive-care unit patients. J Infect Dis 1993; 121: 425-31.
23. TRIANTAFILO V, FICA A, SILVA M, THOMPSON L. E-test para determinar concentraciones inhibitorias minimas, estimar la diversidad bacteriana e identificar presuntivamente B-lactamasas en cepas de Pseudomonas aeruginosa y Acinetobacter baumannii asociados a infecciones intrahospitalarias. Rev Méd Chile 1997; 125: 149-60.
24. TRAUB WH, SPOHR M. Antimicrobial drug susceptibility of clinical isolates of Acinetobacter species (A baumannii, A haemolyticus, genospecies 3, and genospecies 6). Antimicrob Ag Chemother 1989; 33: 1617-19.
25. AUBERT G, GUICHARD D, VEDEL G. In vitro activity of cephalosporins alone and combined with sulbactam against various strains of Acinetobacter baumannii with different antibiotic resistance profiles. J Antimicrob Chemother 1996; 37: 155-60.
26. VILA J, MARCOS A, MARCO F, ABDALLA S, VERGARA Y, REIG R ET AL. In vitro antimicrobial production of beta-lactamases, aminoglycoside-modifing enzymes, and chloramphenicol acetyltransferase by and susceptibility of clinical isolates of Acinetobacter baumannii. Antimicrob Ag Chemother 1993; 37: 138-41.
27. DEVAUD M, KAYSER FH, BACHI B. Transposon-mediated multiple antibiotic resistance in Acinetobacter strains. Antimicrob Ag Chemother 1982; 22: 323-9.
28. JOLY-GUILLOU ML, VALLEE E, BERGOGNE-BÉRÉZIN E, PHILIPPON A. Distribution of beta-lactamases and phenotype analysis in clinical strains of Acinetobacter calcoaceticus. J Antimicrob Chemother 1988; 22: 597-604.
29. MOROHOSHI T, SAITO T. B-lactamases and B-lactam antibiotics resistance in Acinetobacter anitratus (syn: A calcoaceticus). J Antimicrob Chemother 1977; 30: 969-73.
30. JOLY-GUILLOU ML, BERGOGNE-BÉRÉZIN E. Presence d'une beta-lactamase a spectre elargi chez in Acinetobacter baumannii. Presse Med 1990; 19: 672-3.
31. OBARA M, NAKAI T. Mechanisms of resistance to B-lactam antibiotics in Acinetobacter calcoaceticus. J Antimicrob Chemother 1991; 28: 791-800.
32. LAMBERT T, GERVAUD G, COURVALIN P. Transferable amikacin resistance in Acinetobacter ssp due to a new type of 3'aminoglycoside phosphotransferase. Antimicrob Ag Chemother 1988; 32: 15-9.
33. VILA J, RUIZ J, GOÑI P, MARCOS A, JIMÉNEZ DE ANTA T. Mutation in the gyrA gene of quinolone-resistant clinical isolates of Acinetobacter baumannii. Antimicrob Ag Chemother 1995; 39: 1201-03.
34. MOREAU NJ, HOUOT S, JOLY-GUILLOU ML, BERGOGNE-BÉRÉZIN E. Characterization of DNA gyrase and measurement of drug accumulation in clinical isolates of Acinetobacter baumannii resistant to fluoroquinolones. J Antimicrob Chemother 1996; 38: 1079-83.
35. AUBERT G, GRIMONT F, MICHEL V, ZÉNI F, PAIN P, VAUTRIN AC ET AL. Acinetobacter baumannii outbreak isolates characterized by three typing methods. Eur J Clin Microbiol Infect Dis 1995; 14: 1095-100.
36. SEIFERT H, SCHULZE A, BAGINSKI R, PULVERER G. Comparison of four different methods for epidemiologic typing of Acinetobacter baumannii. J Clin Microbiol 1994; 32: 1816-19.
37. BELLO H, GONZÁLEZ G, DOMÍNGUEZ M, ZEMELMAN R, GARCÍA A, MELLA S. Activity of selected B-lactams, ciprofloxacin, and amikacin against different Acinetobacter baumannii biotypes from Chilean hospitals. Diagn Microbiol Infect Dis 1997; 28: 183-6.
38. TANKOVIC J, LEGRAND P, DE GATINES G, CHEMINEAU V, BRUN-BUISSON C, DUVAL J. Characterization of a hospital outbreak imipenem-resistant Acinetobacter baumannii by phenotypic and genotypic typing methods. J Clin Microbiol 1994; 32: 2677-81.
39. URBAN C, GO E, MARIANO N, BERGER BJ, AVRAHAM I, RUDIN D, RAHAL JJ. Effect of sulbactan on infections caused by two imipenem-resistant Acinetobacter calcoaceticus subsp anitratus strains. J Infect Dis 1993; 167: 448-51.